References
- Lee MM, Donahoe PK, Hasegawa T, Silverman B, Crist GB, Best S, Hasegawa Y, Noto RA, Schoenfeld D, MacLaughlin DT. Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. J Clin Endocrinol Metab 1996;81:571–576.
- Ingraham HA, Hirokawa Y, Roberts LM, Mellon SH, McGee E, Nachtigal MW, Visser JA. Autocrine and paracrine Mullerian inhibiting substance hormone signaling in reproduction. Recent Prog Horm Res 2000;55:53–67; discussion 67–68.
- Rey R. Endocrine, paracrine and cellular regulation of postnatal anti-Mullerian hormone secretion by sertoli cells. Trends Endocrinol Metab 1998;9:271–276.
- Lane AH, Lee MM. Clinical applications of Mullerian inhibiting substance in patients with gonadal disorders. Endocrinologist 1999;9:208–215.
- Fujisawa M, Yamasaki T, Okada H, Kamidono S. The significance of anti-Mullerian hormone concentration in seminal plasma for spermatogenesis. Hum Reprod 2002;17:968–970.
- Fenichel P, Rey R, Poggioli S, Donzeau M, Chevallier D, Pointis Gl. Anti-Mullerian hormone as a seminal marker for spermatogenesis in non-obstructive azoospermia. Hum Reprod 1999;14:2020–2024.
- Zalata AA, Hassan AH, Nada HA, Bragais FM, Agarwal A, Mostafa T. Follicle-stimulating hormone receptor polymorphism and seminal anti-Mullerian hormone in fertile and infertile men. Andrologia 2008;40:392–397.
- Duvilla E, Lejeune H, Trombert-Paviot B, Gentil-Perret A, Tostain J, Levy R. Significance of inhibin B and anti-Mullerian hormone in seminal plasma: a preliminary study. Fertil Steril 2008;89:444–448.
- Al-Qahtani A, Muttukrishna S, Appasamy M, Johns Cranfield M, Visser JA, Themmen APN, Groome NP. Development of a sensitive enzyme immunoassay for anti-Mullerian hormone and the evaluation of potential clinical applications in males and females. Clin Endocrinol 2005;63:267–273.
- Goulis DG, Iliadou PK, Tsametis C, Gerou S, Tarlatzis BC, Bontis IN, Papadimas I. Serum anti-Mullerian hormone levels differentiate control from subfertile men but not men with different causes of subfertility. Gynecol Endocrinol 2008;24:158–160.
- Isikoglu M, Ozgur K, Oehninger S, Ozdem S, Seleker M. Serum anti-Mullerian hormone levels do not predict the efficiency of testicular sperm retrieval in men with non-obstructive azoospermia. Gynecol Endocrinol 2006;22:256–260.
- Goulis DG, Tsametis C, Iliadou PK, Polychronou P, Kantartzi PD, Tarlatzis BC, Bontis IN, Papadimas I. Serum inhibin B and anti-Mullerian hormone are not superior to follicle-stimulating hormone as predictors of the presence of sperm in testicular fine-needle aspiration in men with azoospermia. Fertil Steril 2009;91:1279–1284.
- Tüttelmann F, Dykstra N, Themmen AP, Visser JA, Nieschlag E, Simoni M. Anti-Mullerian hormone in men with normal and reduced sperm concentration and men with maldescended testes. Fertil Steril 2009;91:1812–1819.
- La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio AC, Stabile G, Volpe A. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update 2010;16:113–130.
- Eskenazi B, Wyrobek AJ, Sloter E, Kidd SA, Moore L, Young S, Moore D. The association of age and semen quality in healthy men. Hum Reprod 2003;18:447–454.
- Cardona Maya W, Berdugo J, Cadavid Jaramillo A. The effects of male age on semen parameters: analysis of 1364 men attending an andrology center. Aging Male 2009;12:100–103.
- Fisch H, Goluboff ET, Olson JH, Feldshuh J, Broder SJ, Barad DH. Semen analysis in 1283 men from the United States over a 25-year period: no decline in quality. Fertil Steril 1996;65:1009–1014.
- Winkle T, Rosenbusch B, Gagsteiger F, Paiss T, Zoller N. The correlation between male age, sperm quality and sperm DNA fragmentation in 320 men attending a fertility center. Assist Reprod Genet 2009;26:41–46.